PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-5.12%
Cash & equivalents declining -5.12% while Healthcare shows 0.00% growth. Howard Marks would investigate if this cash drain is temporary or signals deeper issues.
No Data
No Data available this quarter, please select a different quarter.
-5.12%
Cash + STI yoy growth ≥ 1.5x the Healthcare median of -0.01%. Joel Greenblatt would see a liquidity advantage if effectively redeployed.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
820.83%
Exceeding 1.5x Healthcare median of 0.00%. Jim Chanos might suspect questionable capitalization or one-time items inflating current assets.
-4.22%
Below half the Healthcare median of 0.00%. Jim Chanos would question if the company faces working capital strain.
-17.65%
PP&E growth below half of Healthcare median of 0.00%. Jim Chanos would suspect potential underinvestment or strategic shift away from core assets.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Below half Healthcare median of 0.00%. Jim Chanos suspects the firm is missing out on growth or is financially constrained.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Above 1.5x Healthcare median of 0.00%. Jim Chanos sees a red flag for intangible or questionable expansions in the balance sheet.
-47.54%
Below half the Healthcare median of 0.00%. Jim Chanos sees a sharp divergence from peers, possibly a sign of strategic retreat or capital shortage.
No Data
No Data available this quarter, please select a different quarter.
-4.84%
Below half the Healthcare median of 0.00%. Jim Chanos might see potential stagnation or distress vs. peers.
46.70%
Payables growth above 1.5x Healthcare median of 0.00%. Jim Chanos might see a warning sign of stressed supplier payments.
-26.38%
Above 1.5x Healthcare median of 0.00%. Jim Chanos might see a short-term leverage spike, raising red flags for near-term solvency.
No Data
No Data available this quarter, please select a different quarter.
126.45%
≥ 1.5x the Healthcare median of 0.00%. Joel Greenblatt sees a robust subscription base vs. peers.
265.71%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a potential short-term burden spike.
63.25%
Above 1.5x Healthcare median of 2.15%. Jim Chanos suspects potential working capital strain.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.00%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a red flag in ballooning future obligations.
No Data
No Data available this quarter, please select a different quarter.
63.16%
Above 1.5x Healthcare median of 0.16%. Jim Chanos suspects an alarming rise in overall leverage.
No Data
No Data available this quarter, please select a different quarter.
-3.23%
≥ 1.5x Healthcare median of -1.15%. Joel Greenblatt sees stronger retained profit growth vs. peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.40%
Below half Healthcare median of 0.00%. Jim Chanos suspects slower net worth growth or losses vs. peers.
-4.84%
Below half Healthcare median of 0.00%. Jim Chanos suspects a major slowdown or distress.
-100.00%
Below half Healthcare median of 0.00%. Jim Chanos sees potential underinvestment or forced liquidation vs. peers.
-26.37%
Above 1.5x Healthcare median of 0.00%. Jim Chanos suspects a big rise in leverage. Check coverage carefully.
5.01%
Above 1.5x Healthcare median 1.39%. Jim Chanos sees a big jump in net debt. Potential leverage red flag.